C.I. MedicalLtd Balance Sheet Health

Finanzielle Gesundheit Kriterienprüfungen 2/6

C.I. MedicalLtd hat ein Gesamteigenkapital von ¥20.1B und eine Gesamtverschuldung von ¥17.2B, wodurch sich der Verschuldungsgrad auf 85.3% beläuft. Die Gesamtaktiva und Gesamtpassiva betragen ¥42.0B bzw. ¥21.9B. C.I. MedicalLtd Das EBIT des Unternehmens beträgt ¥2.6B, so dass der Zinsdeckungsgrad -163.3 beträgt. Das Unternehmen verfügt über Barmittel und kurzfristige Anlagen in Höhe von ¥1.3B.

Wichtige Informationen

85.3%

Verhältnis von Schulden zu Eigenkapital

JP¥17.19b

Verschuldung

Zinsdeckungsgrad	-163.3x
Bargeld	JP¥1.31b
Eigenkapital	JP¥20.15b
Gesamtverbindlichkeiten	JP¥21.90b
Gesamtvermögen	JP¥42.05b

Jüngste Berichte zur Finanzlage

Keine Aktualisierungen

Recent updates

Introducing C.I. MedicalLtd (TYO:3540), The Stock That Zoomed 114% In The Last Year

Feb 18

Should You Be Adding C.I. MedicalLtd (TYO:3540) To Your Watchlist Today?

Jan 31

Can C.I. MedicalLtd (TYO:3540) Keep Up These Impressive Returns?

Jan 13

Could The Market Be Wrong About C.I. Medical Co.,Ltd. (TYO:3540) Given Its Attractive Financial Prospects?

Dec 26

Is C.I. Medical Co.,Ltd. (TYO:3540) Potentially Undervalued?

Dec 08

Can You Imagine How Jubilant C.I. MedicalLtd's (TYO:3540) Shareholders Feel About Its 118% Share Price Gain?

Nov 20

The C.I. MedicalLtd (TYO:3540) Share Price Is Up 60% And Shareholders Are Holding On

Jul 07

Analyse der Finanzlage

Kurzfristige Verbindlichkeiten: 3540Die kurzfristigen Aktiva des Unternehmens (¥18.0B) decken seine kurzfristigen Passiva (¥21.4B) nicht.

Langfristige Verbindlichkeiten: 3540Die kurzfristigen Vermögenswerte des Unternehmens (¥18.0B) übersteigen seine langfristigen Verbindlichkeiten (¥490.0M).

Geschichte und Analyse des Verhältnisses von Schulden zu Eigenkapital

Verschuldungsgrad: 3540Die Nettoverschuldung im Verhältnis zum Eigenkapital (78.8%) wird als hoch angesehen.

Schulden abbauen: 3540Das Verhältnis von Schulden zu Eigenkapital ist in den letzten 5 Jahren von 0% auf 85.3% gestiegen.

Schuldendeckung: 3540Der operative Cashflow des Unternehmens ist negativ, so dass die Schulden nicht ausreichend gedeckt sind.

Zinsdeckung: 3540 mehr Zinsen einnimmt als er zahlt, so dass die Deckung der Zinszahlungen kein Problem darstellt.

C.I. MedicalLtd Balance Sheet Health

Finanzielle Gesundheit Kriterienprüfungen 2/6

Wichtige Informationen

Jüngste Berichte zur Finanzlage

Recent updates

Investor sentiment improves as stock rises 20%

C.I. Medical Co.,Ltd. to Report Q2, 2024 Results on Aug 13, 2024

First quarter 2024 earnings released: EPS: JP¥24.70 (vs JP¥52.11 in 1Q 2023)

C.I. Medical Co.,Ltd. (TSE:3540) signed sale and purchase agreement to acquire Nissen Holdings Co., Ltd. from Seven & i Net Media Co., Ltd. for ¥4.1 billion.

C.I. Medical Co.,Ltd. (TSE:3540) signed sale and purchase agreement to acquire Nissen Holdings Co., Ltd. from Seven & i Net Media Co., Ltd. for ¥4.1 billion.

C.I. Medical Co.,Ltd., Annual General Meeting, Mar 26, 2024

Full year 2023 earnings released: EPS: JP¥208 (vs JP¥252 in FY 2022)

C.I. Medical Co.,Ltd. to Report Fiscal Year 2023 Results on Feb 13, 2024

Upcoming dividend of JP¥25.00 per share at 0.6% yield

Investor sentiment improves as stock rises 15%

New major risk - Financial position

Third quarter 2023 earnings released: EPS: JP¥51.29 (vs JP¥57.01 in 3Q 2022)

C.I. Medical Co.,Ltd. to Report Q3, 2023 Results on Nov 14, 2023

New major risk - Earnings quality

Second quarter 2023 earnings released: EPS: JP¥70.50 (vs JP¥65.91 in 2Q 2022)

C.I. Medical Co.,Ltd. to Report Q2, 2023 Results on Aug 08, 2023

First quarter 2023 earnings released: EPS: JP¥52.10 (vs JP¥86.91 in 1Q 2022)

Full year 2022 earnings: EPS misses analyst expectations

Now 23% undervalued after recent price drop

Consensus EPS estimates fall by 16%, revenue upgraded

Full year 2022 earnings: EPS misses analyst expectations

C.I. Medical Co.,Ltd. to Report Fiscal Year 2022 Results on Feb 14, 2023

Upcoming dividend of JP¥28.50 per share

Third quarter 2022 earnings released: EPS: JP¥57.01 (vs JP¥65.91 in 3Q 2021)

Third quarter 2022 earnings released: EPS: JP¥56.99 (vs JP¥65.91 in 3Q 2021)

C.I. Medical Co.,Ltd. (TSE:3540) agreed to acquire Naiki Shiken Ltd. from Yuichi Naiki and Yuriko Naiki.

C.I. Medical Co.,Ltd. to Report Q3, 2022 Results on Nov 08, 2022

C.I. Medical Co.,Ltd. (TSE:3540) agreed to acquire Sakura Dental Laboratory from Akira Ochi and Katsumi Ochi.

Second quarter 2022 earnings released: EPS: JP¥65.90 (vs JP¥67.61 in 2Q 2021)

C.I. Medical Co.,Ltd. to Report Q2, 2022 Results on Aug 09, 2022

First quarter 2022 earnings: EPS misses analyst expectations

Price target decreased to JP¥4,300

C.I. Medical Co.,Ltd. to Report Q1, 2022 Results on May 10, 2022

Investor sentiment improved over the past week

C.I. Medical Co.,Ltd., Annual General Meeting, Mar 24, 2022

Full year 2021 earnings: EPS misses analyst expectations

Now 22% undervalued after recent price drop

Now 20% undervalued after recent price drop

Price target decreased to JP¥5,300

Third quarter 2021 earnings released: EPS JP¥65.89 (vs JP¥81.10 in 3Q 2020)

Second quarter 2021 earnings released: EPS JP¥67.61 (vs JP¥65.10 in 2Q 2020)

Investor sentiment deteriorated over the past week

Looop Inc. agreed to acquire 60% stake in Niigata Prefectural Electric Power Co., Ltd. and Yotsuba Electric Power Co., Ltd. from C.I. Medical Co.,Ltd. (JASDAQ:3540).

Investor sentiment improved over the past week

First quarter 2021 earnings released: EPS JP¥87.40 (vs JP¥48.50 in 1Q 2020)

Here's Why We Think C.I. MedicalLtd (TYO:3540) Is Well Worth Watching

Returns on Capital Paint A Bright Future For C.I. MedicalLtd (TYO:3540)

Full year 2020 earnings released: EPS JP¥292 (vs JP¥151 in FY 2019)

Investor sentiment improved over the past week

Should You Investigate C.I. Medical Co.,Ltd. (TYO:3540) At JP¥5,450?

New 90-day low: JP¥5,490

Analysts increase EPS estimates to JP¥320

Introducing C.I. MedicalLtd (TYO:3540), The Stock That Zoomed 114% In The Last Year

C.I. Medical Co.,Ltd. (JASDAQ:3540) acquired 22.4% stake in Fuji Dental Lab Co., Ltd.

Full year 2020 earnings released: EPS JP¥292 (vs JP¥151 in FY 2019)

Revenue and earnings beat expectations

Should You Be Adding C.I. MedicalLtd (TYO:3540) To Your Watchlist Today?

Yosuke Oda Kaki and Keisuke Hori agreed to acquire an additional 60% stake in One Recto Holdings Co., Ltd. from C.I. Medical Co.,Ltd. (JASDAQ:3540).

New 90-day low: JP¥5,900

Can C.I. MedicalLtd (TYO:3540) Keep Up These Impressive Returns?

C.I. Medical Co.,Ltd. to Report Fiscal Year 2020 Results on Feb 21, 2021

Could The Market Be Wrong About C.I. Medical Co.,Ltd. (TYO:3540) Given Its Attractive Financial Prospects?

Upcoming Dividend of JP¥15.00 Per Share

New 90-day low: JP¥6,150

Is C.I. Medical Co.,Ltd. (TYO:3540) Potentially Undervalued?

New 90-day low: JP¥6,520

Analysts increase EPS estimates to JP¥251

Can You Imagine How Jubilant C.I. MedicalLtd's (TYO:3540) Shareholders Feel About Its 118% Share Price Gain?

Third quarter 2020 earnings released: EPS JP¥81.10

Revenue and earnings beat expectations

C.I. Medical Co.,Ltd. (JASDAQ:3540) reached an agreement to acquire 60% stake in Niigata Prefectural Electric Power Co., Ltd. from Takashi Kakuya, Chairman and Director of Niigata Prefectural Electric Power Co., Ltd.

Revenue and earnings beat expectations

Third quarter 2020 earnings released: EPS JP¥81.10

New 90-day high: JP¥8,810

C.I. Medical Co.,Ltd. to Report Q3, 2020 Results on Nov 10, 2020